Clauser E, Bihoreau C, Monnot C, Teutsch B, Conchon S, Davies E, Corvol P
INSERM U36, Collège de France, Paris.
Diabete Metab. 1992;18(2 Pt 2):129-36.
Angiotensin II is an octapeptide resulting from the enzymatic cascade of the renin-angiotensin system and involved in vasoconstriction and aldosterone secretion. The extensive use of converting enzyme inhibitors recently suggested that angiotensin II may have a specific action on growth of its target tissues. Cellular models confirm that angiotensin II is able to produce in vitro a cellular hypertrophy of many cell types. Nevertheless a controversy was developed on the real possibility for angiotensin II to act on cell division. Some cells, such as adrenocortical cells, present a clear induction of their division by angiotensin II, but contradictory results were obtained on vascular smooth muscle cells. The mechanism by which angiotensin II induces hypertrophy of its target tissues, is largely unknown but may involve a direct action on proto-oncogene synthesis, or an indirect action on growth factor secretion. The nature of the angiotensin II receptor involved in these mechanisms has to be identified.
血管紧张素II是肾素-血管紧张素系统酶促级联反应产生的一种八肽,参与血管收缩和醛固酮分泌。最近转化酶抑制剂的广泛应用表明,血管紧张素II可能对其靶组织的生长具有特定作用。细胞模型证实,血管紧张素II能够在体外使多种细胞类型发生细胞肥大。然而,关于血管紧张素II作用于细胞分裂的实际可能性存在争议。一些细胞,如肾上腺皮质细胞,血管紧张素II可明显诱导其分裂,但在血管平滑肌细胞上得到了相互矛盾的结果。血管紧张素II诱导其靶组织肥大的机制很大程度上尚不清楚,但可能涉及对原癌基因合成的直接作用,或对生长因子分泌的间接作用。必须确定参与这些机制的血管紧张素II受体的性质。